Comparison of gemeprost and vaginal misoprostol in first trimester mifepristone-induced abortion

Contraception

Volumn 72, Issue 1, 2005, Pages 28-32

  Svendsen, Pernille Fog ^a   Rørbye, Christina ^a   Vejborg, Thomas ^a   Nilas, Lisbeth ^a  

^a Mental Health Center Glostrup   (Denmark)

Author keywords

Efficacy; Gemeprost vaginal misoprostol; Medical abortion; Side effects

Indexed keywords

ANALGESIC AGENT; GEMEPROST; METOCLOPRAMIDE; MIFEPRISTONE; MISOPROSTOL; MORPHINE;

ADULT; ARTICLE; BLEEDING; COMPARATIVE STUDY; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GESTATION PERIOD; HUMAN; INDUCED ABORTION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NAUSEA AND VOMITING; NURSE; PAIN; PREGNANCY TERMINATION; RECORDING; RETROSPECTIVE STUDY; SCORING SYSTEM; TREATMENT OUTCOME;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INDUCED; ADULT; ALPROSTADIL; CHORIONIC GONADOTROPIN; FEMALE; GESTATIONAL AGE; HUMANS; MISOPROSTOL; PREGNANCY; RETROSPECTIVE STUDIES;

EID: 20444470375     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2004.11.010     Document Type: Article

References (23)

1. D.R. Urquhart, A. Templeton, and F. Shinewi UK Multicentre Trial. The efficacy and tolerance of mifepristone and prostaglandin in first trimester termination of pregnancy Br. J. Obstet. Gynaecol. 97 1990 480 486
2. A. Ulmann, L. Silvestre, and L. Chemama Medical termination of early pregnancy with mifepristone (RU486) followed by a prostaglandin analogue Acta Obstet. Gynecol. Scand. 71 1992 278 283
3. J. Bartley, A. Brown, R. Elton, and D.T. Baird Double blind randomized trial of mifepristone in combination with vaginal gemeprost or misoprostol for induction of abortion up to 63 days gestation Hum. Reprod. 16 2001 2098 2102
4. H. el-Refaey, D. Rajasekar, M. Abdalla, L. Calder, and A. Templeton Induction of abortion with mifepristone (RU486) and oral or vaginal misoprostol N. Engl. J. Med. 332 1995 983 987
5. E.A. Schaff, S.L. Fielding, and C. Westhoff Randomized trial of oral versus vaginal misoprostol at one day after mifepristone for early medical abortion Contraception 64 2001 81 85
6. E.A. Schaff, S.L. Fielding, and C. Westhoff Randomized trial of oral versus vaginal misoprostol 2 days after mifepristone 200 mg for abortion up to 63 days of pregnancy Contraception 66 2002 247 250
7. WHO Task Force on Post-ovulatory Methods of Fertility Regulation Termination of pregnancy with reduced doses of mifepristone BMJ 307 1993 532 536
8. C. McKinley, K.J. Thong, and D.T. Bard The effect of dose of mifepristone and gestation on the efficacy of medical abortion with mifepristone and misoprostol Hum. Reprod. 8 1993 1502 1505
9. P.W. Ashok, G.C. Penney, G.M. Flett, and A. Templeton An effective regimen for early medical abortion: a report of 2000 consecutive cases Hum. Reprod. 13 1998 2962 2965
10. E.A. Schaff, S.L. Fielding, S.H. Eisinger, L.S. Stadalius, and L. Fuller Low-dose mifepristone followed by vaginal misoprostol at 48 hours for abortion up to 63 days Contraception 61 2000 41 46
11. J. Bartley, S. Tong, D. Everington, and D.T. Baird Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost Contraception 62 2000 297 303
12. C. Rorbye, M. Nørgaard, V. Vestermark, and L. Nilas Medical abortion: defining success and categorizing failures Contraception 68 2003 247 251
13. C. Rorbye, M. Nørgaard, and L. Nilas Prediction of late failure after medical abortion from serial β-hCG measurements and ultrasonography Hum. Reprod. 19 2004 85 89
14. D.T. Baird, N. Sukchareon, and K.J. Thong Randomised trial of misoprostol and Cervagem in combination with a reduced dose of mifepristone for induction of abortion Hum. Reprod. 10 1995 1521 1527
15. D.R. Urquhart, A.A. Templeton, and F. Shinewi The efficacy and tolerance of mifepristone and prostaglandin in termination of pregnancy of less than 63 days gestation. UK Multicentre Study-final results Contraception 55 1997 1 5
16. E.V. Gouk, K. Lincoln, A. Khair, J. Haslock, J. Knight, and D.J. Cruickshank Medical termination of pregnancy at 63 to 83 days gestation Br. J. Obstet. Gynaecol. 106 1999 535 539
17. P.W. Ashok, A. Templeton, P.T. Wagaarachchi, and G.M.M. Flett Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases Br. J. Obstet. Gynaecol. 109 2002 1281 1289
18. H. Hamoda, P.W. Ashok, J. Dow, G.M.M. Flett, and A. Templeton A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days gestation Contraception 68 2003 335 338
19. M.W. Rodger, A.F. Logan, and D.T. Baird Induction of early abortion with mifepristone (RU486) and two different doses of prostaglandin pessary (gemeprost) Contraception 39 1989 497 502
20. I.M. Spitz, C.W. Bardin, L. Benton, and A. Robbins Early pregnancy termination with mifepristone and misoprostol in the United States N. Engl. J. Med. 338 1998 1241 1247
21. E. Wiebe Pain control in medical abortion Int. J. Gynaecol. Obstet. 74 2001 275 280
22. M.D. Creinin, and T. Shulman Effect of nonsteroidal anti-inflammatory drugs on the action of misoprostol in a regimen for early abortion Contraception 56 1997 165 168
23. C. Rorbye, M. Nørgaard, and L. Nilas Medical versus surgical abortion: comparing satisfaction and potential confounders in a partly randomised study Hum. Reprod. 20 2005 834 838